Industry reports
Editor highlights

Publication dates

Cell Therapy Research Reports, April 2014

You might be interested in: medical equipment, therapeutics, cancer, more »


 

1-10 of about 200 reports for Cell Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 327 companies plus partners developing 426 Androgen Receptor drugs in 1397 developmental projects in cancer. ...

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

Ecomic Co.,Ltd

Ecomic Co.,Ltd

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Ecomic Co.,Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

International Stem Cell Corporation

International Stem Cell Corporation

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for International Stem Cell Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

Notch Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 249 companies plus partners ...

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • March 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 242 companies plus partners developing ...

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...


» Read our Company Profiles

2 Companies for Cell Therapy

Bioheart Inc.

United States

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.